In this paper, we investigate the feasibility of adapting OrganoPlate® technology for therapy selection for breast cancer. The work is a collaboration with Prof. Richard Weinschilbaum and Dr. Liewei Wang from the Mayo Clinic in Minnesota.
Karlijn Wilschut, Senior Scientist at Mimetas and Oksana Sirenko, Research Scientist at Molecular Devices wrote this application note on a quantitative, confocal high-content imaging method, enabling high-throughput phenotypic assessment of treatment effects upon the viability and morphology of 3D neuronal cultures in OrganoPlate®.
During this two-day hands-on training hosted by MIMETAS you will learn everything about the current applications of organ-on-a-chip within the pharmaceutical industry.
This review evaluates Organ-on-a-Chip efforts published over the last two years in light of end-user adoption aspects.
In this webinar, MIMETAS and Molecular Devices present OrganoPlates® as a novel microfluidic culture platform enabling long-term, membrane-free 3D co-culture models in a microtiter plate format.
On December 9, 2016 our paper on 3D neuronal cultures in OrganoPlates was published in Nature Scientific Reports.
The NIH has awarded MIMETAS and the University of Pittsburgh a prestigious SBIR grant to develop a Liver-on-a-Chip platform for high throughput discovery and development.